Skip to content
No prescription No appointment Free US standard shipping
0 Buy now
Open navigation menu

THE JOURNEY TO OTC

The Opill® story

From prescription history to over-the-counter access: discover the milestones behind the product.

Explore Opill
The Opill® story

Expanding access to daily contraception

A product history shaped by research, consumer involvement and a change in access.

An additional way to get birth control

Prescription requirements can add appointments and other practical steps to obtaining a daily oral contraceptive. Opill’s move to over-the-counter availability added a prescription-free option in the United States.

The product’s journey

The milestones below describe the history of norgestrel tablets and Opill’s development by its manufacturer. They are not the founding dates or research activities of this independently operated retailer.

The journey from Rx to OTC

Five milestones in the history of the product.

Use the left and right arrow keys to browse events. Use Home or End to reach the beginning or end.

  1. 1973

    1973 product-history milestone

    Prescription approval

    The FDA approved norgestrel tablets for prescription daily contraception.

  2. 2015

    Research for the over-the-counter switch

    The switch research begins

    HRA Pharma began the research needed for an application to move Opill from prescription to over-the-counter use.

  3. 2022

    Application-submission milestone

    The application is submitted

    After research and consumer testing, the manufacturer submitted its application for nonprescription availability.

  4. 2023

    FDA over-the-counter approval milestone

    FDA approval for OTC use

    On July 13, the FDA approved Opill as the first nonprescription daily oral contraceptive in the United States.

  5. 2024

    Opill reaches online and retail shelves

    Available without a prescription

    Opill became available online and through US retailers as an over-the-counter daily birth control pill.

Consumer involvement along the way

The manufacturer describes several ways consumers contributed during development.

Labeling and comprehension

01

Labeling and comprehension

Studies and surveys examined whether people could understand the package information and follow directions.

Packaging decisions

02

Packaging decisions

Consumer input helped inform the name, packaging and color choices associated with Opill.

Consumer voices

03

Consumer voices

Consumers and advocates gave testimony during the FDA advisory-committee process.

Information belongs alongside access

Having more options works best with clear product information. The Drug Facts and consumer leaflet explain how to take Opill, possible side effects and when it should not be used.

Explore the product’s daily-use guidance before choosing a pack.

How Opill works
Information belongs alongside access

About this storefront

Product history and store support are kept distinct.

An independent retailer

This independently operated storefront offers Opill. Opill is a product of Perrigo, and the product name and packaging identify the goods offered. This store does not claim to be the manufacturer or to have conducted the research described above.

Choose your daily routine

Browse one, two or three single packs. Each single pack contains 28 tablets, and the product page shows the current prices and multi-pack savings.

Explore Opill
Choose your daily routine

Read the label. Make an informed choice.

Do not use Opill if you have or ever had breast cancer. Read every warning in the Drug Facts and consumer leaflet. This is not emergency contraception and does not protect against sexually transmitted infections. Ask a healthcare professional if you have questions. Read the complete leaflet.